CA Patent

CA2391534A1 — Selective cellular targeting: multifunctional delivery vehicles

Assigned to Drug Innovation and Design Inc · Expires 2001-05-25 · 25y expired

What this patent protects

Published without an

USPTO Abstract

Published without an

Drugs covered by this patent

lutetium-lu-177-vipivotide-tetraxetan (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN)

Patent Metadata

Patent number: CA2391534A1
Jurisdiction: CA
Classification: —
Expires: 2001-05-25
Drug substance claim: No
Drug product claim: No
Assignee: Drug Innovation and Design Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.